endocrinologist semaglutide vs. PCOS: The Shocking New Research! A Pediatric Breaks It All Down 1-year outcomes of semaglutide, tirzepatide,

These foods are also harder to digest and may cause dumping-like symptomsrapid gastric emptying that leads to weakness, dizziness, and abdominal cramping

However, St-Pierre notes, While some observational studies suggest associations with improved IBD-related outcomes, these findings should be interpreted cautiously given reliance on administrative data and surrogate end points. Overall, the available data are reassuring, St-Pierre says

For people with reproductive hormone imbalances, ipamorelin offers a way to support these systems without pushing other hormones out of balance

In September 2025, the FDA granted accelerated approval to elamipretide (under the brand name FORZINITY) for Barth syndrome, making it the first FDA-approved mitochondria-targeted therapy